Tiverton Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.58M | Hold |
19,591
| – | – | 0.05% | 237 |
|
|
2019
Q2 | $1.42M | Sell |
19,591
-3,629
| -16% | -$263K | 0.05% | 230 |
|
|
2019
Q1 | $2.17M | Hold |
23,220
| – | – | 0.09% | 166 |
|
|
2018
Q4 | $1.69M | Sell |
23,220
-17,455
| -43% | -$1.27M | 0.1% | 131 |
|
|
2018
Q3 | $3.56M | Sell |
40,675
-5,898
| -13% | -$516K | 0.17% | 101 |
|
|
2018
Q2 | $4.59M | Buy |
46,573
+13,573
| +41% | +$1.34M | 0.23% | 90 |
|
|
2018
Q1 | $3.93M | Buy |
+33,000
| New | +$3.93M | 0.27% | 87 |
|